Literature DB >> 23269349

Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.

M A Kruse1, E S Holmes, J A Balko, S Fernandez, D C Brown, M H Goldschmidt.   

Abstract

Osteosarcoma is the most common bone tumor in dogs. However, current literature focuses primarily on appendicular osteosarcoma. This study examined the prognostic value of histological and clinical factors in flat and irregular bone osteosarcomas and hypothesized that clinical factors would have a significant association with survival time while histological factors would not. All osteosarcoma biopsy samples of the vertebra, rib, sternum, scapula, or pelvis were reviewed while survival information and clinical data were obtained from medical records, veterinarians, and owners. Forty-six dogs were included in the analysis of histopathological variables and 27 dogs with complete clinical data were included in the analysis of clinical variables. In the histopathologic cox regression model, there was no significant association between any histologic feature of osteosarcoma, including grade, and survival time. In the clinical cox regression model, there was a significant association between the location of the tumor and survival time as well as between the percent elevation of alkaline phosphatase (ALP) above normal and survival time. Controlling for ALP elevation, dogs with osteosarcoma located in the scapula had a significantly greater hazard for death (2.8) compared to dogs with tumors in other locations. Controlling for tumor location, every 100% increase in ALP from normal increased the hazard for death by 1.7. For canine osteosarcomas of the flat and irregular bones, histopathological features, including grade do not appear to be rigorous predictors of survival. Clinical variables such as increased ALP levels and tumor location in the scapula were associated with decreased survival times.

Entities:  

Keywords:  dogs; grading system; osteosarcoma; prognosis

Mesh:

Substances:

Year:  2012        PMID: 23269349     DOI: 10.1177/0300985812471542

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  5 in total

1.  Pubectomy and stereotactic radiotherapy for the treatment of a non-resectable sacral osteosarcoma causing pelvic canal obstruction in a dog.

Authors:  Victoria D Randall; Sarah E Boston; Heather L Gardner; Lynn Griffin; Michelle L Oblak; Lyndsay Kubicek
Journal:  Can Vet J       Date:  2016-09       Impact factor: 1.008

Review 2.  Canine and murine models of osteosarcoma.

Authors:  Jessica Beck; Ling Ren; Shan Huang; Erika Berger; Kathleen Bardales; Joshua Mannheimer; Christina Mazcko; Amy LeBlanc
Journal:  Vet Pathol       Date:  2022-03-26       Impact factor: 3.157

3.  Clinicopathological and molecular profiles of Babesia vogeli infection and Ehrlichia canis coinfection.

Authors:  Thanakorn Rawangchue; Sivapong Sungpradit
Journal:  Vet World       Date:  2020-07-09

Review 4.  Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.

Authors:  Siobhan Simpson; Mark David Dunning; Simone de Brot; Llorenç Grau-Roma; Nigel Patrick Mongan; Catrin Sian Rutland
Journal:  Acta Vet Scand       Date:  2017-10-24       Impact factor: 1.695

5.  Machine Learning-Based Prediction of Lymph Node Metastasis Among Osteosarcoma Patients.

Authors:  Wenle Li; Yafeng Liu; Wencai Liu; Zhi-Ri Tang; Shengtao Dong; Wanying Li; Kai Zhang; Chan Xu; Zhaohui Hu; Haosheng Wang; Zhi Lei; Qiang Liu; Chunxue Guo; Chengliang Yin
Journal:  Front Oncol       Date:  2022-04-20       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.